通过 Romberg 测试筛查站立平衡的人，并通过串联步行筛查步行平衡
September 1st, 2023
7.7K views
本文介绍了使用两种规范的、快速的、低技术含量的平衡测试来筛查人们站立和行走平衡障碍的程序。
科学挑战是在不依赖大量技术的情况下创造可靠和有效的测量平衡的技术。这些测试应适用于实地研究、小型诊所以及在医疗保健技术有限的地方筛查患者。测试足够多的不同年龄段的健康个体，以及足够多的前庭疾病和其他平衡问题患者至关重要。
招募足够多的人可能具有挑战性，但有必要确定这些测试是否可以有效地筛查个人的各种平衡问题。临床医生和研究人员可以在复杂的医疗环境中使用这些测试，也可以在小型诊所、疗养院、社区护理设施、用于基于人群的流行病学研究的移动实验室，甚至在飞行后宇航员的着陆点使用这些测试。这些数据有助于临床决策。
概述
本文描述了使用两个规范化、快速、低技术的平衡测试来筛查个体的站立和行走平衡障碍的程序。这些测试设计用于各种医疗环境，包括小型诊所和社区护理机构。
关键研究组成部分
科学领域
- 神经科学
- 临床评估
- 平衡测试
背景
- 有效的平衡测量技术对临床决策至关重要。
- 测试应适用于低技术环境。
- 招募多样化的参与者对验证测试至关重要。
- 平衡障碍可能显著影响生活质量。
研究目的
- 开发可靠的平衡筛查测试。
- 评估患有前庭系统疾病的个体的平衡。
- 为临床医生提供有效的患者评估工具。
使用的方法
- 参与者在中等密度泡沫上进行CTSIB测试。
- 计时试验评估平衡维持的持续时间。
- 串联行走测试测量脚跟到脚趾行走的能力。
- 数据根据不同年龄组的既定标准进行分析。
主要结果
- 幼儿在平衡测试中的得分比年长儿童低。
- 年长受试者的正确串联步数比10至59岁的受试者少。
- 得分随年龄显著下降。
- 测试能有效区分正常和异常的平衡表现。
结论
- 开发的测试可靠用于筛查平衡障碍。
- 它们可以在各种临床和研究环境中使用。
- 需要进一步的研究来扩展参与者数据库。
常见问题
什么是CTSIB测试？
CTSIB测试通过测量一个人在不同条件下能够保持平衡的时间长度来评估感觉整合和平衡。
测试如何进行？
参与者在泡沫上进行平衡测试，并在计时的情况下完成串联行走试验。
谁可以使用这些平衡测试？
临床医生和研究人员可以在各种医疗环境中使用这些测试，包括诊所和社区设施。
研究中包含了哪些年龄组？
研究包括不同年龄范围的健康个体，以及患有前庭系统疾病的患者。
关于年龄和平衡的主要发现是什么？
研究发现平衡得分随年龄下降，尤其是在幼儿和老年人中。
Executive Industry Relevance
Reliable, low-tech balance screening methods such as tandem walking and CTSIB enable scalable assessment of vestibular and sensory integration function across diverse populations. These protocols support early identification of balance impairments, facilitating risk stratification and mechanistic de-risking in both clinical and field research settings. Their rapid, standardized administration enhances predictive confidence for downstream translational and epidemiological studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables objective quantification of balance deficits linked to vestibular dysfunction.
- Supports functional target validation by correlating sensory integration with clinical phenotypes.
- Facilitates biological de-risking through standardized, reproducible screening outputs.
Screening & Assay Development
- Provides validated, rapid protocols for assessing balance in diverse environments.
- Delivers reproducible, quantitative readouts suitable for large-scale screening initiatives.
- Enables assay standardization and cross-site comparability for multi-center studies.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints for vestibular and neurological disorders.
- Supports continuity from early discovery through preclinical and population-based research.
- Informs risk-adjusted advancement decisions by linking functional outcomes to mechanistic hypotheses.
Pipeline & Workflow Integration
These balance screening protocols integrate into the discovery-to-translational continuum, supporting hypothesis testing, cohort stratification, and endpoint validation in both controlled and resource-limited settings.
- Discovery Biology: Facilitates hypothesis-driven assessment of sensory and vestibular function.
- Screening: Provides rapid, reproducible, and quantitative balance metrics for cohort selection.
- Analytics: Enables statistical comparison of balance performance across age groups and clinical conditions.
- Translational Research: Bridges early screening with preclinical and epidemiological studies for biomarker alignment.
- Enterprise Reuse: Offers a scalable, low-infrastructure capability for repeated use across studies and populations.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in balance-related endpoints.
- Operational Value: Promotes standardization, reproducibility, and scalability in both clinical and field settings.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling early risk identification.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of balance-related therapeutic programs.
Implementation Considerations
- Requires personnel trained in standardized test administration and scoring.
- Needs minimal instrumentation: stopwatch, foam, and clear walking space.
- Demands cross-team adherence to protocol for reproducibility.
- Adaptable to various age groups and clinical populations with established normative data.
- Limited by participant ability to follow instructions and stand unsupported for 30 seconds.
Biopharma FAQs
Why does null hypothesis testing matter for CTSIB and tandem walking?
Null hypothesis testing enables objective determination of whether observed balance performance differs significantly from established normative data, supporting robust target validation and mechanistic de-risking in balance research.
How does independent variable isolation fit tandem walking screening?
Isolating variables such as head movement or visual input in tandem walking allows precise attribution of balance deficits to specific sensory or vestibular mechanisms, enhancing discovery-stage confidence.
What do quantitative dependent variable measurements enable in CTSIB?
Quantitative timing and step-count outputs from CTSIB provide reproducible metrics for comparing balance across cohorts, enabling statistical analysis and cross-study benchmarking.
Why are replication requirements critical for cross-functional balance studies?
Replication ensures that balance screening results are reliable and comparable across sites, supporting collaboration between clinical, translational, and epidemiological research teams.
What statistical analysis capabilities are required before implementing balance screening?
Teams must be able to compare individual scores to normative data, assess statistical significance, and interpret age- or condition-specific thresholds to inform clinical or research decisions.
